Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-02
2007-01-02
Tucker, Zachary C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S117000, C544S350000
Reexamination Certificate
active
10781928
ABSTRACT:
The present invention relates to 8-amino-aryl-substituted imidazopyrazines which modulate the activity of protein kinases (“PKs”). The compounds of this invention are therefore useful in treating disorders related to abnormal PK activity. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
REFERENCES:
patent: 5869485 (1999-02-01), Missbach
patent: 6919340 (2005-07-01), Currie et al.
patent: 6919341 (2005-07-01), Paruch et al.
patent: 0 166 609 (1986-01-01), None
patent: 0 480 713 (1992-04-01), None
patent: WO 94/18198 (1994-08-01), None
patent: WO 01/27110 (2001-04-01), None
patent: WO 02/10170 (2002-02-01), None
patent: WO 02/14321 (2002-02-01), None
patent: WO 02/060492 (2002-08-01), None
Al-Dabbagh and Smith, “Species differences in oxidative drug metabolism: some basic considerations.” Archives of toxicology. Supplement. Archiv fur Toxikologie. supplement, vol. 7, pp. 219-231 (1984).
Hans Bundgaard, Design of Prodrugs, p. 1. © 1985 Elsevier Science Publishers.
Richard B. Silverman, The Organic Chemistry of Drug Design and Drug Action, pp. 352-400. © 1992 Academic Press, Inc.
Barraclough et al., “Sites of Protonation in Cardiotonic Polyazaindolizines by NMR Spectroscopy,”Magnetic Resonance in Chemistry, 1991, pp. 468-475, vol. 29, John Wiley & Sons, Ltd.
Colotta et al., “Synthesis of some tricyclic heteroaromatic systems and their A1and A2aadenosine binding activity,”Eur. J. Med. Chem., 1995, pp. 133-139, vol. 30, Elsevier Paris.
MacCoss et al., “Synthesis and Biological Evaluation of Nucleosides Containing 8-Amino-imidazo[1,2-a]pyrazine as an Isosteric Replacement for Adenin [1],”Journal of Heterocyclic Chemistry, Oct.-Nov. 1993, pp. 1213-1220, vol. 30, No. 5.
Zurbonsen et al., “Antiproliferative Effects of Imidazol[1,2-a]pyrazine Derivatives on the Dami Cell Line,”Biochemical Pharmacology, 1997, pp. 365-371, vol. 54, Elsevier Science Inc.
Guan Huiping
Harris, Jr. G. Davis
Huang Ping
Liang Congxin
Sun Connie Li
Liptak Vincent P.
Sugen Inc.
Tucker Zachary C.
Zielinski Bryan C.
LandOfFree
Use of 8-amino-aryl-substituted imidazopyrazines as kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 8-amino-aryl-substituted imidazopyrazines as kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 8-amino-aryl-substituted imidazopyrazines as kinase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3760782